BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19638697)

  • 1. [Biochemical markers of bone turnover. New aspect. Nitric oxide synthase and bone metabolism].
    Sabanai K; Tsutsui M; Sakai A; Nakamura T; Shimokawa H; Yanagihara N
    Clin Calcium; 2009 Aug; 19(8):1133-41. PubMed ID: 19638697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic disruption of all NO synthase isoforms enhances BMD and bone turnover in mice in vivo: involvement of the renin-angiotensin system.
    Sabanai K; Tsutsui M; Sakai A; Hirasawa H; Tanaka S; Nakamura E; Tanimoto A; Sasaguri Y; Ito M; Shimokawa H; Nakamura T; Yanagihara N
    J Bone Miner Res; 2008 May; 23(5):633-43. PubMed ID: 18433298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms.
    Nakata S; Tsutsui M; Shimokawa H; Suda O; Morishita T; Shibata K; Yatera Y; Sabanai K; Tanimoto A; Nagasaki M; Tasaki H; Sasaguri Y; Nakashima Y; Otsuji Y; Yanagihara N
    Circulation; 2008 Apr; 117(17):2211-23. PubMed ID: 18413498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical markers of bone turnover. New aspect. Bone metabolism movement in various sports and physical activities].
    Ishikawa T; Sakuraba K
    Clin Calcium; 2009 Aug; 19(8):1125-31. PubMed ID: 19638696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthase I mediates osteoclast activity in vitro and in vivo.
    Jung JY; Lin AC; Ramos LM; Faddis BT; Chole RA
    J Cell Biochem; 2003 Jun; 89(3):613-21. PubMed ID: 12761894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous ligation-mediated bone adaptation is NOS 3 dependent.
    Bergula AP; Haidekker MA; Huang W; Stevens HY; Frangos JA
    Bone; 2004 Mar; 34(3):562-9. PubMed ID: 15003804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trigeminal nitric oxide synthase expression correlates with new bone formation during distraction osteogenesis.
    de Albuquerque RF; Aparecida Del Bel E; Brentegani LG; Moura de Oliveira MT; Mardegan Issa JP
    Calcif Tissue Int; 2008 Apr; 82(4):309-15. PubMed ID: 18330484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase.
    Armour KE; Armour KJ; Gallagher ME; Gödecke A; Helfrich MH; Reid DM; Ralston SH
    Endocrinology; 2001 Feb; 142(2):760-6. PubMed ID: 11159848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers].
    Miura M
    Clin Calcium; 2009 Aug; 19(8):1160-9. PubMed ID: 19638700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of bone mass and bone turnover by neuronal nitric oxide synthase.
    van't Hof RJ; Macphee J; Libouban H; Helfrich MH; Ralston SH
    Endocrinology; 2004 Nov; 145(11):5068-74. PubMed ID: 15297441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical markers of bone turnover. New aspect. Changes in bone turnover markers during fracture healing].
    Ichimura S; Hasegawa M
    Clin Calcium; 2009 Aug; 19(8):1102-8. PubMed ID: 19638693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover].
    Ohnaka K; Takayanagi R
    Clin Calcium; 2009 Aug; 19(8):1118-24. PubMed ID: 19638695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous myocardial infarction and nitric oxide synthase.
    Tsutsui M; Nakata S; Shimokawa H; Otsuji Y; Yanagihara N
    Trends Cardiovasc Med; 2008 Nov; 18(8):275-9. PubMed ID: 19345314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High bone matrix turnover predicts blood levels of lead among perimenopausal women.
    Machida M; Sun SJ; Oguma E; Kayama F
    Environ Res; 2009 Oct; 109(7):880-6. PubMed ID: 19595303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
    Bonnet N; Pierroz DD; Ferrari SL
    J Musculoskelet Neuronal Interact; 2008; 8(2):94-104. PubMed ID: 18622078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of bone remodeling by nervous system. Possible roles of pituitary hormones for bone metabolism].
    Takeuchi Y
    Clin Calcium; 2010 Dec; 20(12):1857-64. PubMed ID: 21123938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic assessments utilizing saliva: part 2 osteoporosis and use of saliva to measure bone turnover.
    Koka S; Forde MD; Khosla S
    Int J Prosthodont; 2006; 19(1):53-60. PubMed ID: 16479761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-intensity electrical stimulation counteracts the effects of ovariectomy on bone tissue of rats: effects on bone microarchitecture, viability of osteocytes, and nitric oxide expression.
    Lirani-Galvão AP; Chavassieux P; Portero-Muzy N; Bergamaschi CT; Silva OL; Carvalho AB; Lazaretti-Castro M; Delmas PD
    Calcif Tissue Int; 2009 Jun; 84(6):502-9. PubMed ID: 19458889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontiers in Live Bone Imaging Researches. Functional cross talk between bone and nervous system].
    Fukuda T; Takeda S
    Clin Calcium; 2015 Jun; 25(6):891-8. PubMed ID: 26017867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.